Preemptive Use of Recombinant Activated Factor VII: Many Questions but Few Answers

Canadian Journal of Anaesthesia - United States
doi 10.1007/bf03022495
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Compatible Solute Influence on Nucleic Acids: Many Questions but Few Answers

Saline Systems
2008English

Intraoperative Use of Recombinant Activated Factor VII During Complex Aortic Surgery

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2012English

Recombinant Activated Factor VII and Aortic Surgery

European Journal of Vascular and Endovascular Surgery
SurgeryCardiovascular MedicineCardiology
2013English

Potential Thrombogenic Complications With the Use of Recombinant Activated Factor VII in Combat Trauma

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2007English

The Use of Recombinant Activated Factor VII for Refractory Bleeding Post Complex Cardiothoracic Surgery

Anaesthesia and Intensive Care
Critical CareAnesthesiologyPain MedicineIntensive Care Medicine
2006English

Successful Use of Recombinant Activated Factor VII for Postoperative Associated Haemorrhage: A Case Report

Cases Journal
2008English

Use of Recombinant Factor VII in Cardiac Surgery

Recent Patents on Cardiovascular Drug Discovery
2012English

Elective Surgery on Factor VIII Inhibitor Patients Using Continuous Infusion of Recombinant Activated Factor VII

Thrombosis and Haemostasis
Hematology
2001English

Recombinant Activated Factor VII (rFVIIa) Treatment of Refractory Bleeding in Cardiac Surgical Patients

Journal of Anesthesia & Clinical Research
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy